why choose us

First received: August 20, 2024

Clinical Trial: A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: CBD Pharmacokinetics

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-Label, 4-Way Crossover, Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions

Brief Summary: Cannabidiol (CBD), derived from the Cannabis sativa plant, is being investigated for its potential health benefit without the psychoactive properties and adverse reactions that arise from the use of delta-9-tetrahydrocannabinol (?9-THC).Few studies have characterized the pharmacokinetic (PK) effects and safety of oral CBD administration.Epidiolex (Epidyolex), an oil form of CBD, is the only marketed monotherapy approved by the United States Food and Drug Administration (FDA) and Health Canada.Delivery of a CBD in…

Read more